Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy

Contributed by: GlobeNewswire

Tags

study

More Like This

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Sonablate Expands Leadership to Accelerate Growth in Incision-Free Prostate Care Solutions

GlobeNewswire associated0

Sonablate Announces Landmark Global Strategic Alliance with Eleven Ventures to Advance AI-Powered Precision Medicine

GlobeNewswire associated0

KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles

PR Newswire associated0

Insightec Marks 10,000 Patients Treated Across Europe, Middle East and Africa (EMEA) With MR-Guided Focused Ultrasound

Histotripsy patient Marie and her husband Steve after Marie's histotripsy treatment of her liver tumors by Evan S.K. Ong, M.D., MS, FACS, with Providence Swedish in Seattle after the FDA De Novo grant. (Photo: Business Wire)

HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

PR Newswire associated0

FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025